About this trial
This study aims to develop an explainable machine learning model that takes into account the characteristics of cardiopulmonary interactions. This model will enable early prediction of acute lung injury (ALI) in patients undergoing major liver surgery. The research will create a digital early-warning system for ALI, thereby supporting clinical diagnosis and treatment decisions. This, in turn, should help reduce the incidence and mortality rates associated with ALI.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Undergoing major liver surgery (including two-segment or more hepatectomy, liver transplantation, etc.)
Voluntary participation with signed informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Beijing Tsinghua Chang Gung Hospital
Lead sponsor
Huangdao District People's Hospital of Qingdao
Collaborator
Peking University International Hospital
Collaborator
The First Affiliated Hospital of Army Medical University (Southwest Hospital)
Collaborator